152 related articles for article (PubMed ID: 36941700)
1. BCL7A is silenced by hypermethylation to promote acute myeloid leukemia.
Patiño-Mercau JR; Baliñas-Gavira C; Andrades A; Benitez-Cantos MS; Rot AE; Rodriguez MI; Álvarez-Pérez JC; Cuadros M; Medina PP
Biomark Res; 2023 Mar; 11(1):32. PubMed ID: 36941700
[TBL] [Abstract][Full Text] [Related]
2. Frequent mutations in the amino-terminal domain of BCL7A impair its tumor suppressor role in DLBCL.
Baliñas-Gavira C; Rodríguez MI; Andrades A; Cuadros M; Álvarez-Pérez JC; Álvarez-Prado ÁF; de Yébenes VG; Sánchez-Hernández S; Fernández-Vigo E; Muñoz J; Martín F; Ramiro AR; Martínez-Climent JA; Medina PP
Leukemia; 2020 Oct; 34(10):2722-2735. PubMed ID: 32576963
[TBL] [Abstract][Full Text] [Related]
3. BCL7A and BCL7B potentiate SWI/SNF-complex-mediated chromatin accessibility to regulate gene expression and vegetative phase transition in plants.
Lei Y; Yu Y; Fu W; Zhu T; Wu C; Zhang Z; Yu Z; Song X; Xu J; Liang Z; Lü P; Li C
Nat Commun; 2024 Jan; 15(1):935. PubMed ID: 38296999
[TBL] [Abstract][Full Text] [Related]
4. SMARCB1 Deficiency Integrates Epigenetic Signals to Oncogenic Gene Expression Program Maintenance in Human Acute Myeloid Leukemia.
Chatterjee SS; Biswas M; Boila LD; Banerjee D; Sengupta A
Mol Cancer Res; 2018 May; 16(5):791-804. PubMed ID: 29483235
[TBL] [Abstract][Full Text] [Related]
5. BCL7A-containing SWI/SNF/BAF complexes modulate mitochondrial bioenergetics during neural progenitor differentiation.
Wischhof L; Lee HM; Tutas J; Overkott C; Tedt E; Stork M; Peitz M; Brüstle O; Ulas T; Händler K; Schultze JL; Ehninger D; Nicotera P; Salomoni P; Bano D
EMBO J; 2022 Dec; 41(23):e110595. PubMed ID: 36305367
[TBL] [Abstract][Full Text] [Related]
6. SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities.
Andrades A; Peinado P; Alvarez-Perez JC; Sanjuan-Hidalgo J; García DJ; Arenas AM; Matia-González AM; Medina PP
Mol Cancer; 2023 Feb; 22(1):39. PubMed ID: 36810086
[TBL] [Abstract][Full Text] [Related]
7. Zinc finger protein 382 is downregulated by promoter hypermethylation in pediatric acute myeloid leukemia patients.
Tao YF; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Xu LX; Li ZH; Wang NN; Du XJ; Sun LC; Zhao H; Fang F; Su GH; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
Int J Mol Med; 2014 Dec; 34(6):1505-15. PubMed ID: 25319049
[TBL] [Abstract][Full Text] [Related]
8. The promoter of miR-663 is hypermethylated in Chinese pediatric acute myeloid leukemia (AML).
Yan-Fang T; Jian N; Jun L; Na W; Pei-Fang X; Wen-Li Z; Dong W; Li P; Jian W; Xing F; Jian P
BMC Med Genet; 2013 Jul; 14():74. PubMed ID: 23870168
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73.
van Doorn R; Zoutman WH; Dijkman R; de Menezes RX; Commandeur S; Mulder AA; van der Velden PA; Vermeer MH; Willemze R; Yan PS; Huang TH; Tensen CP
J Clin Oncol; 2005 Jun; 23(17):3886-96. PubMed ID: 15897551
[TBL] [Abstract][Full Text] [Related]
10. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.
Tao YF; Xu LX; Lu J; Hu SY; Fang F; Cao L; Xiao PF; Du XJ; Sun LC; Li ZH; Wang NN; Su GH; Li YH; Li G; Zhao H; Li YP; Xu YY; Zhou HT; Wu Y; Jin MF; Liu L; Zhu XM; Ni J; Wang J; Xing F; Zhao WL; Pan J
J Exp Clin Cancer Res; 2015 Jan; 34(1):4. PubMed ID: 25609158
[TBL] [Abstract][Full Text] [Related]
11. SWI/SNF Blockade Disrupts PU.1-Directed Enhancer Programs in Normal Hematopoietic Cells and Acute Myeloid Leukemia.
Chambers C; Cermakova K; Chan YS; Kurtz K; Wohlan K; Lewis AH; Wang C; Pham A; Dejmek M; Sala M; Loeza Cabrera M; Aguilar R; Nencka R; Lacorazza HD; Rau RE; Hodges HC
Cancer Res; 2023 Apr; 83(7):983-996. PubMed ID: 36662812
[TBL] [Abstract][Full Text] [Related]
12. Metallothionein III (MT3) is a putative tumor suppressor gene that is frequently inactivated in pediatric acute myeloid leukemia by promoter hypermethylation.
Tao YF; Xu LX; Lu J; Cao L; Li ZH; Hu SY; Wang NN; Du XJ; Sun LC; Zhao WL; Xiao PF; Fang F; Li YH; Li G; Zhao H; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
J Transl Med; 2014 Jun; 12():182. PubMed ID: 24962166
[TBL] [Abstract][Full Text] [Related]
13. Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia.
Tao YF; Fang F; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Li ZH; Wang NN; Xu LX; Du XJ; Sun LC; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
BMC Cancer; 2015 Oct; 15():756. PubMed ID: 26490736
[TBL] [Abstract][Full Text] [Related]
14. DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia.
Sun GK; Tang LJ; Zhou JD; Xu ZJ; Yang L; Yuan Q; Ma JC; Liu XH; Lin J; Qian J; Yao DM
Cancer Med; 2019 Oct; 8(14):6393-6402. PubMed ID: 31486300
[TBL] [Abstract][Full Text] [Related]
15. Identification of GLIPR1 tumor suppressor as methylation-silenced gene in acute myeloid leukemia by microarray analysis.
Xiao YH; Li XH; Tan T; Liang T; Yi H; Li MY; Zeng GQ; Wan XX; Qu JQ; He QY; Li JH; Chen Y; Xiao ZQ
J Cancer Res Clin Oncol; 2011 Dec; 137(12):1831-40. PubMed ID: 21922325
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia.
Gao XN; Lin J; Li YH; Gao L; Wang XR; Wang W; Kang HY; Yan GT; Wang LL; Yu L
Oncogene; 2011 Aug; 30(31):3416-28. PubMed ID: 21399664
[TBL] [Abstract][Full Text] [Related]
17. The C/EBPdelta tumor suppressor is silenced by hypermethylation in acute myeloid leukemia.
Agrawal S; Hofmann WK; Tidow N; Ehrich M; van den Boom D; Koschmieder S; Berdel WE; Serve H; Müller-Tidow C
Blood; 2007 May; 109(9):3895-905. PubMed ID: 17234736
[TBL] [Abstract][Full Text] [Related]
18. Promoter methylation of the candidate tumor suppressor gene TCF21 in myelodysplastic syndrome and acute myeloid leukemia.
Gu Y; Zhou JD; Xu ZJ; Zhang TJ; Wen XM; Ma JC; Ji RB; Yuan Q; Zhang W; Chen Q; Lin J; Qian J
Am J Transl Res; 2019; 11(6):3450-3460. PubMed ID: 31312357
[TBL] [Abstract][Full Text] [Related]
19. Exquisite Sensitivity to Dual BRG1/BRM ATPase Inhibitors Reveals Broad SWI/SNF Dependencies in Acute Myeloid Leukemia.
Rago F; Rodrigues LU; Bonney M; Sprouffske K; Kurth E; Elliott G; Ambrose J; Aspesi P; Oborski J; Chen JT; McDonald ER; Mapa FA; Ruddy DA; Kauffmann A; Abrams T; Bhang HC; Jagani Z
Mol Cancer Res; 2022 Mar; 20(3):361-372. PubMed ID: 34799403
[TBL] [Abstract][Full Text] [Related]
20. GPX3 hypermethylation serves as an independent prognostic biomarker in non-M3 acute myeloid leukemia.
Zhou JD; Yao DM; Zhang YY; Ma JC; Wen XM; Yang J; Guo H; Chen Q; Lin J; Qian J
Am J Cancer Res; 2015; 5(5):1786-94. PubMed ID: 26175946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]